Structure-based design of potent CDK4 selective inhibitor.

被引：0

作者：

Honma, T ^{[1
]}

Hayashi, K ^{[1
]}

Kawanishi, N ^{[1
]}

Yoshizumi, T ^{[1
]}

Hashimoto, N ^{[1
]}

Sugimoto, T ^{[1
]}

Nakamura, K ^{[1
]}

Takaki, T ^{[1
]}

Machida, T ^{[1
]}

Fukasawa, K ^{[1
]}

Hirai, H ^{[1
]}

Iwama, T ^{[1
]}

Ikeura, C ^{[1
]}

Ikuta, M ^{[1
]}

Kamata, K ^{[1
]}

Suzuki-Takahashi, I ^{[1
]}

Hayama, T ^{[1
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 221卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

136-MEDI

引用

页码：U24 / U24

页数：1

共 50 条

[21] Unveiling Betulinic Acid as a Potent CDK4 Inhibitor for Cancer Therapeutics
El-Gamal, Basiouny
A-Elgadir, Thoraya
Patel, Ayyub Ali
Abd Ellatif, Mohamed
Nasif, Khalid Ali
Alsamghan, Awad Saeed
Malik, Arshi
Abd Elrouf, Mohamed Babiker
Alghawanmeh, Imad
Saeed, Marwa
Ahmed, Osama Haroun
Makki, Soha
Elshaikh, Haitham
Ali, Yasser
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (04) : 1117 - 1129
[22] STRUCTURE-BASED DESIGN OF THE FIRST POTENT AND SELECTIVE INHIBITOR OF HUMAN NONPANCREATIC SECRETORY PHOSPHOLIPASE-A(2)
SCHEVITZ, RW
BACH, NJ
CARLSON, DG
CHIRGADZE, NY
CLAWSON, DK
DILLARD, RD
DRAHEIM, SE
HARTLEY, LW
JONES, ND
MIHELICH, ED
OLKOWSKI, JL
SNYDER, DW
SOMMERS, C
WERY, JP
NATURE STRUCTURAL BIOLOGY, 1995, 2 (06): : 458 - 465
[23] Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure
Kawanishi, Nobuhiko
Sugimoto, Tetsuya
Shibata, Jun
Nakamura, Kaori
Masutani, Kouta
Ikuta, Marl
Hirai, Hiroshi
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (19) : 5122 - 5126
[24] A novel approach for the development of selective Cdk4 inhibitors: Library design based on locations of Cdk4 specific amino acid residues
Honma, T
Yoshizumi, T
Hashimoto, N
Hayashi, K
Kawanishi, N
Fukasawa, K
Takaki, T
Ikeura, C
Ikuta, M
Suzuki-Takahashi, I
Hayama, T
Nishimura, S
Morishima, H
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) : 4628 - 4640
[25] Structure-based design of a selective heparanase inhibitor as an antimetastatic agent
Ishida, K
Hirai, G
Murakami, K
Teruya, T
Simizu, S
Sodeoka, M
Osada, H
MOLECULAR CANCER THERAPEUTICS, 2004, 3 (09) : 1069 - 1077
[26] FCN-437: A novel, potent and selective oral inhibitor of CDK4/6 for the treatment of solid tumors
Lin, Shu
Zhao, Xingdong
Li, Tongshuang
Zhang, Huajie
Tan, Haohan
Wang, Xianlong
Jiang, Lihua
Liu, Yanxin
Sun, Jing
Li Linghu
Liu, Qihong
Li, Zhifu
Zhang, Weipeng
Wang, Weibo
CANCER RESEARCH, 2019, 79 (13)
[27] Structure-based design of potent CDK1 inhibitors derived from olomoucine
Pascal Furet
Juerg Zimmermann
Hans-Georg Capraro
Thomas Meyer
Patricia Imbach
Journal of Computer-Aided Molecular Design, 2000, 14 : 403 - 409
[28] Structure-based design of potent CDK1 inhibitors derived from olomoucine
Furet, P
Zimmermann, J
Capraro, HG
Meyer, T
Imbach, P
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2000, 14 (05) : 403 - 409
[29] Structure-Based Design of a Potent and Selective YTHDC1 Ligand
Zalesak, Frantisek
Nai, Francesco
Herok, Marcin
Bochenkova, Elena
Bedi, Rajiv K.
Li, Yaozong
Errani, Francesco
Caflisch, Amedeo
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9516 - 9535
[30] Structure-Based Design of Potent and Selective CK1γ Inhibitors
Huang, Hongbing
Acquaviva, Lisa
Berry, Virginia
Bregman, Howard
Chakka, Nagasree
O'Connor, Anne
DiMauro, Erin F.
Dovey, Jennifer
Epstein, Oleg
Grubinska, Barbara
Goldstein, Jon
Gunaydin, Hakan
Hua, Zihao
Huang, Xin
Huang, Liyue
Human, Jason
Long, Alex
Newcomb, John
Patel, Vinod F.
Saffran, Doug
Serafino, Randy
Schneider, Steve
Strathdee, Craig
Tang, Jin
Turci, Susan
White, Ryan
Yu, Violeta
Zhao, Huilin
Wilson, Cindy
Martin, Matthew W.
ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1059 - 1064

← 1 2 3 4 5 →